FDA Inspection 1229492 — ImpactLife
The FDA completed an inspection of ImpactLife on Aug 15, 2024 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Springfield, IL (United States)